Arcus Biosciences, Inc.·4

Dec 17, 8:36 PM ET

Nuyten Dimitry SA 4

4 · Arcus Biosciences, Inc. · Filed Dec 17, 2024

Insider Transaction Report

Form 4
Period: 2024-12-15
Nuyten Dimitry SA
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2024-12-15$16.08/sh7,856$126,32487,518 total
Footnotes (1)
  • [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.

Documents

1 file
  • 4
    wk-form4_1734485783.xmlPrimary

    FORM 4